Achieve Life Sciences, Inc.

3.95 USD
-0.01 (-0.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Achieve Life Sciences, Inc. stock is down -21% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 15 February’s closed higher than January.

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company is based in Vancouver, Canada and has license agreements with Sopharma AD and University of Bristol.